PolyPeptide Group AG (LON: 0AAJ)
London
· Delayed Price · Currency is GBP · Price in CHF 25.95
-2.05 (-7.32%)
Jan 31, 2025, 4:27 PM BST
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 748.48 million as of January 31, 2025. Its market cap has increased by 66.89% in one year.
Market Cap
748.48M
Enterprise Value
805.84M
Revenue
274.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.95
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.04B to 748.48M, a decrease of -63.30%. That is a compound annual growth rate of -23.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 748.48M | -9.31% |
| Dec 30, 2024 | 825.31M | 53.37% |
| Dec 29, 2023 | 538.12M | -28.11% |
| Dec 30, 2022 | 748.55M | -79.59% |
| Dec 30, 2021 | 3.67B | 79.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.89B |
| GSK plc | 57.33B |
| Haleon | 33.92B |
| Smith & Nephew | 9.00B |
| Hikma Pharmaceuticals | 5.08B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.39B |